GWP
RMD icon

Gen-Wealth Partners’s ResMed RMD Stock Holding History

Gen-Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.3K Sell
458
-224
-33% -$46.4K 0.02% 347
2026
Q1 		$153K Sell
682
-246
-27% -$61.3K 0.05% 273
2025
Q4 		$224K Sell
928
-110
-11% -$28.1K 0.07% 247
2025
Q3 		$284K Sell
1,038
-43
-4% -$11.7K 0.1% 208
2025
Q2 		$279K Sell
1,081
-50
-4% -$11.9K 0.11% 181
2025
Q1 		$253K Sell
1,131
-303
-21% -$70.7K 0.11% 185
2024
Q4 		$328K Sell
1,434
-8
-0.6% -$1.93K 0.14% 156
2024
Q3 		$350K Buy
1,442
+335
+30% +$74.9K 0.15% 154
2024
Q2 		$212K Buy
1,107
+230
+26% +$46.7K 0.1% 195
2024
Q1 		$174K Buy
+877
New +$161K 0.09% 229

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Gen-Wealth Partners's RMD Position: Q2 2026 in Review

Gen-Wealth Partners reduced its ResMed (RMD) stake by 33% in Q2 2026, selling an estimated $46.4K and leaving 458 shares worth $89.3K. The position accounts for 0.02% of the portfolio, ranked #347.

Gen-Wealth Partners first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $350K in Q3 2024. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Gen-Wealth Partners held 458 shares of ResMed worth $89.3K as of Q2 2026.
  • Gen-Wealth Partners sold 224 ResMed shares in Q2 2026, an estimated $46.4K.
  • ResMed made up 0.02% of Gen-Wealth Partners's portfolio in Q2 2026, its #347 holding.
  • Gen-Wealth Partners first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Gen-Wealth Partners's ResMed position peaked at $350K in Q3 2024.
  • 485 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.